France Respiratory Drug Market 2019: Global Industry Analysis Report to 2025

France respiratory drug market was valued more than $1.3 billion in 2018 and is anticipated to grow at a substantial rate of 6.0% during the forecast period. The rising prevalence of chronic respiratory diseases, increasing geriatric population, and technological advancement are the major factors augmenting the growth of the respiratory drug market in the country. Moreover, the presence of market players in the country is also influencing the market growth of the country. For instance, Air Liquide S.A., in April 2018, acquired a French start-up company EOVE for the extension of service offering of home healthcare activities. In January 2018, the company acquired the respiratory division of Thimar Al Jazirah Company (TAC) for geographical expansion and enter into the Saudi Arabia market. In September 2017, Air Liquide acquired Sogo Sangyo Kabushiki Kaisha for expanding its healthcare business in Japan.

To Request a Sample of our Report on France Respiratory Drug Market: https://www.omrglobal.com/request-sample/france-respiratory-drug-market

The France respiratory drug market is segmented on the basis of the route of administration, application, and end-user. Based on the route of administration, the market is classified into oral, injectable, and inhalable. Moreover, on the basis of application, the market has been classified into asthma and COPD diseases. The asthma disease application segment dominated the regional market in 2018 and is further estimated to follow the same trend over the forecast period. This is mainly due to the high prevalence of asthma in the country. In addition, based on the end-user, homecare and hospitals and clinics have been analyzed.

(Get 15% Discount on Buying this Report)

A full Report of France Respiratory Drug Market is Available @ https://www.omrglobal.com/industry-reports/france-respiratory-drug-market

France Respiratory Drug Market Segmentation

By Route of Administration

· Oral

· Injectable

· Inhalable

· France Respiratory Drug Market by Application

· Asthma

· Chronic Obstructive Pulmonary Disease (COPD)

By End-User

· Homecare

· Hospitals and Clinics

Company Profiles

· Air Liquide S.A.

· Aradigm Corp.

· AstraZeneca PLC

· Baxter International Inc.

· Boehringer Ingelheim International GmbH

· F. Hoffmann-La Roche Ltd.

· GlaxoSmithKline PLC

· Merck & Co.

· Novartis AG

· Omron Healthcare Inc.

· Pfizer Inc.

· Pulmatrix Inc.

· ResMed Corp.

· Savara, Inc.

· unovion Pharmaceuticals

· Takeda Pharmaceutical Company Ltd.

· Teva Pharmaceuticals Industries Ltd.

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.